Cubist Systematic Strategies, LLC Bolt Biotherapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.48 - $2.61 $6,488 - $11,442
-4,384 Reduced 30.0%
10,228 $15,000
Q2 2022

Aug 15, 2022
BUY
$1.41 - $2.91 $20,602 - $42,520
14,612 New
14,612 $30,000
Q1 2022

May 16, 2022
SELL
$2.74 - $4.82 $51,805 - $91,131
-18,907 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.19 - $13.97 $49,023 - $163,449
11,700 Added 162.34%
18,907 $93,000
Q3 2021

Nov 15, 2021
BUY
$11.15 - $18.6 $80,358 - $134,050
7,207 New
7,207 $91,000

Others Institutions Holding BOLT

# of Institutions
33
Shares Held
19.1M
Call Options Held
0
Put Options Held
0
View Full List

About Bolt Biotherapeutics, Inc.

BOLT Quotes by TradingView
  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $18.4M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email